Stephani Schmitz participates with a poster to EHA2024

In her poster, Stephani  presentes her research on the molecular mechanisms driving CSNK1A1 mutation selection in the bone marrow of del(5q) MDS patients.

Utilizing murine models and various cellular assays, the research found that the E98V mutation confers a growth advantage and affects ferroptosis signaling pathways.

These findings suggest that targeting ferroptosis could be a potential therapeutic strategy for del(5q) MDS.

For more information, follow the link: EHA Library – The official digital education library of European Hematology Association (EHA) (ehaweb.org)